News
Brief news reports on Tuberculosis
By
Stop TB Partnership
Published: April 25, 2015, 9:05 p.m.·
Tags:
TB programs
India undertook the largest ever TB programme review over the last two weeks. Following this, the Ministry of Health of India launched on 23 April, a bold Call to Action for a TB Free India.
Read More →
By
Stop TB Partnership
Published: April 25, 2015, 8:42 p.m.·
Tags:
Drug-resistant TB,
Treatment,
Access
This is a note for implementers providing a general overview and reviewing the steps they need to take in order to access the drug.
Read More →
By
TB Europe Coalition
Published: April 22, 2015, 10:42 p.m.·
Tags:
TB programs,
Advocacy
As part of a TB Europe Coalition (TBEC) series of field visit, three members of TBEC visited Belarus in November 2014.
Read More →
Published: April 22, 2015, 8:32 p.m.·
Tags:
TB programs,
Vaccines
A major contributor to the number of tuberculosis infections and cases in China will likely be the elderly over the next few decades, requiring a refocus in efforts to control a disease affecting millions of people in the country, according to preliminary new research presented at the Fourth Global Forum on TB Vaccines in Shanghai. The researchers from the London School of Hygiene & Tropical Medicine found that developing a "post-infection" vaccine could reduce overall TB rates in China by almost a third by 2050.
Read More →
By
Ojwang Joe
Published: April 21, 2015, 11:40 p.m.·
Tags:
Vaccines
SHANGHAI, China, Apr 21 – Researchers are now working on a strategy to introduce the safest and most effective Tuberculosis vaccines that reduce the disease worldwide through partnerships and creative mechanisms.
Read More →
By
Catherine Saez
Published: April 21, 2015, 11:27 p.m.·
Tags:
Medicines,
Access,
Advocacy
The World Health Organization is reviewing its list of essential medicines this week. Over 70 candidate medicines are expected to be assessed by an Expert Committee. Some of those medicines are under patent and highly priced, which poses an accessibility challenge.
Read More →
By
Peter Cegielski, Andrew Vernonemail
Published: April 21, 2015, 10:15 p.m.·
Tags:
Treatment
Both protein–energy undernutrition and specific micronutrient deficiencies debilitate the cell-mediated immune system important in protection against tuberculosis.1 However, once tuberculosis develops, the disease itself induces a catabolic state resulting in negative nitrogen balance and micronutrient deficiencies. Generations of clinicians treating patients with tuberculosis believed that nutritional support was crucial to proper patient care. Why, then, has it been so difficult to prove through randomised controlled clinical trials that nutritional interventions improve tuberculosis treatment outcomes? Findings from systematic reviews2, 3, 4, 5, 6 have not shown any clear, consistent benefit in terms of tuberculosis-specific outcomes, although they do show improvements in nutritional status.
Read More →
By
Rasika Rampatige, Charles F Gilksemail
Published: April 21, 2015, 9:51 p.m.·
Tags:
TB epidemiology,
TB care
Active tuberculosis, particularly when extrapulmonary or disseminated, can be extremely difficult to diagnose before death and is often missed, including as a cause of death. Therefore, autopsy studies can be especially informative. In their classic 1960 study, Petersdorf and Beeson1 identified tuberculosis as the most common cause of fever of unknown origin; most cases were extrapulmonary, and although most were diagnosed both before and after death, one case was only identified after death. In the same decade, autopsy played a crucial part in defining cryptic disseminated tuberculosis as a variant of reactivated tuberculosis that occurred particularly in elderly Scottish women and that was difficult to diagnose.2 More recently, autopsy studies have helped delineate the spectrum of HIV-associated disease in Africa and have shown that active tuberculosis in all its forms is a common cause of adult death.3, 4
Read More →
By
National Institutes of Health
Published: April 20, 2015, 10:47 p.m.·
Tags:
Medicines,
Global health,
Public health
Poor quality medicines are a real and urgent threat that could undermine decades of successful efforts to combat HIV/AIDS, malaria and tuberculosis, according to the editors of a collection of journal articles published today. Scientists report up to 41 percent of specimens failed to meet quality standards in global studies of about 17,000 drug samples. Among the collection is an article describing the discovery of falsified and substandard malaria drugs that caused an estimated 122,350 deaths in African children in 2013. Other studies identified poor quality antibiotics, which may harm health and increase antimicrobial resistance. However, new methodologies are being developed to detect problem drugs at the point of purchase and show some promise, scientists say.
Read More →
By
Catherine Saez
Published: April 20, 2015, 8:07 p.m.·
Tags:
Public health,
Medicines
The World Health Organization has announced that its Global Medicines Safety Database is now open to the general public. The database named VigiAccess can now be accessed on any computer or smartphone in the world.
Read More →
Page 554 of 878 · Total posts: 10
←First
553
554
555
Last→